ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Dr Maitreyyee Bhattacharyya speaks at the 2nd ecancer TMC Oncology Congress, which was held at the Tata Medical Center, Kolkata, on 31 September and 1 October 2023.
ESMO 2024: Best practice in HRRm testing in patients with metastatic prostate cancer
Hormonal receptor positive breast cancer adjuvant and metastatic indications
ASCO 2024: Lung cancer highlights
Quality of life and patient satisfaction of Filipinos after breast conservation surgery and intraoperative radiotherapy
ELCC 2024: Latest in EGFR mutant lung cancer; exon 20 mutation focus
The advantages of IORT for early breast cancer treatment
Global adoption of single-shot targeted IORT for breast cancer
The TARGIT-A randomised trial: TARGIT-IORT versus whole breast radiation therapy: long-term local control and survival
Hypofractionated high dose intensity modulated radiotherapy non-inferior for prostate cancer